Literature DB >> 18326007

Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly.

Fleur Descoutures1, Dominique Himbert, Laurent Lepage, Bernard Iung, Delphine Détaint, Didier Tchetche, Eric Brochet, Yves Castier, Jean-Pol Depoix, Patrick Nataf, Alec Vahanian.   

Abstract

AIMS: To assess patient characteristics, therapeutic options, and their results in patients referred to a tertiary centre with on-site capabilities for surgical and percutaneous valvular interventions for the management of severe symptomatic aortic stenosis (AS). METHODS AND
RESULTS: Sixty-six consecutive patients >70 years (83 +/- 6 years) were referred for severe AS. Their mortality risk predicted by the logistic European System for Cardiac Operative Risk Evaluation and the Society of Thoracic Surgeons-Predicted Risk of Mortality scores were on average 20 +/- 14% and 17 +/- 7%, respectively. Thirty-nine patients (59%) were considered at high-risk for surgery or inoperable after multidisciplinary evaluation: 12 (31%) underwent a transfemoral aortic valve implantation and 27 were considered unsuitable and treated medically (n = 16) or with valvuloplasty (n = 7), or were re-directed towards surgery (n = 4). The 27 other patients underwent valve replacement. In-hospital mortality was 9% (6 of 66). There were three hospital deaths in patients treated percutaneously, two in those treated medically, and one after surgery. At 6 months, 10% (6 of 60) of the survivors died: two after valvuloplasty and four after medical treatment.
CONCLUSION: A large proportion of elderly patients referred for management of severe AS have a high-risk profile. The availability of percutaneous valvular interventions increases the number of those who are offered interventions.

Entities:  

Mesh:

Year:  2008        PMID: 18326007     DOI: 10.1093/eurheartj/ehn081

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  15 in total

1.  How to define a poor outcome after transcatheter aortic valve replacement: conceptual framework and empirical observations from the placement of aortic transcatheter valve (PARTNER) trial.

Authors:  Suzanne V Arnold; John A Spertus; Yang Lei; Philip Green; Ajay J Kirtane; Samir Kapadia; Vinod H Thourani; Howard C Herrmann; Nirat Beohar; Alan Zajarias; Michael J Mack; Martin B Leon; David J Cohen
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-09-10

2.  Imaging for approach selection of TAVI: assessment of the aorto-iliac tract diameter by computed tomography-angiography versus projection angiography.

Authors:  E M A Wiegerinck; H A Marquering; N Y Oldenburger; M A Elattar; R N Planken; B A J M De Mol; J J Piek; J Baan
Journal:  Int J Cardiovasc Imaging       Date:  2013-12-11       Impact factor: 2.357

3.  Classical methods to measure aortic valve area in the era of new invasive therapies: still accurate enough?

Authors:  Victoria Delgado; Jeroen J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2008-09-18       Impact factor: 2.357

Review 4.  In vivo imaging and computational analysis of the aortic root. Application in clinical research and design of transcatheter aortic valve systems.

Authors:  Paul Schoenhagen; Alexander Hill; Tim Kelley; Zoran Popovic; Sandra S Halliburton
Journal:  J Cardiovasc Transl Res       Date:  2011-04-12       Impact factor: 4.132

5.  Dual source multidetector CT-angiography before Transcatheter Aortic Valve Implantation (TAVI) using a high-pitch spiral acquisition mode.

Authors:  W Wuest; K Anders; A Schuhbaeck; M S May; S Gauss; M Marwan; M Arnold; S Ensminger; G Muschiol; W G Daniel; M Uder; S Achenbach
Journal:  Eur Radiol       Date:  2011-08-17       Impact factor: 5.315

6.  Multi-detector computed tomography is equivalent to trans-oesophageal echocardiography for the assessment of the aortic annulus before transcatheter aortic valve implantation.

Authors:  Johannes Rixe; Annika Schuhbaeck; Christoph Liebetrau; Helge Moellmann; Holger M Nef; Sebastian Szardien; Roland Brandt; Joern Schmitt; Thomas Neumann; Christian Schneider; Gabriele Krombach; Christian W Hamm; Stephan Achenbach; Andreas Rolf
Journal:  Eur Radiol       Date:  2012-06-12       Impact factor: 5.315

7.  Vascular access site complications after percutaneous transfemoral aortic valve implantation.

Authors:  Philipp Kahlert; Fadi Al-Rashid; Marcel Weber; Daniel Wendt; Torsten Heine; Eva Kottenberg; Matthias Thielmann; Hilmar Kühl; Jürgen Peters; Heinz G Jakob; Stefan Sack; Raimund Erbel; Holger Eggebrecht
Journal:  Herz       Date:  2009-08       Impact factor: 1.443

8.  [Transcatheter aortic valve implantation: surgeon's view].

Authors:  Sabine Bleiziffer; Robert Bauernschmitt; Hendrik Ruge; Domenico Mazzitelli; Christian Schreiber; Andrea Hutter; Anke Opitz; Rüdiger Lange
Journal:  Herz       Date:  2009-08       Impact factor: 1.443

Review 9.  [Surgery or medical therapy for secondary mitral regurgitation?].

Authors:  Arnd Schaefer
Journal:  Herz       Date:  2009-03       Impact factor: 1.443

10.  Urochordates carry multiple genes for goose-type lysozyme and no genes for chicken- or invertebrate-type lysozymes.

Authors:  I W Nilsen; B Myrnes; R B Edvardsen; D Chourrout
Journal:  Cell Mol Life Sci       Date:  2003-10       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.